he principal anticipated outcome of the project is improved public health. The innovative eye drops under development, based on self-emulsifying ophthalmic systems (SEO), will enable effective administration of medicines that are unstable in aqueous environments, including antibiotics. This may make it possible to treat ophthalmic conditions for which convenient and effective treatment options are currently lacking.
SEO technology provides stability of the active substances, patient comfort and the potential for prolonged drug action on the ocular surface, thereby improving treatment effectiveness and reducing the need for frequent administration. Such solutions may contribute not only to better vision and ocular health but also, indirectly, to society’s adaptation to challenges associated with population ageing and climate change.